3. Exam format
⢠Exam date: Held once/ year, next one (18th June 2024)
⢠Exam registration through your national society
⢠Exam fees (400 Euro)
⢠120 MCQ questions over 3 hours
⢠Delivered using online proctoring platform (ProctorUŽ).
19. What to focus on in guidelines?
âAccording to my exam questionsâ
20. Heart failure guidelines
⢠HF diagnosis (Most specific, sensitive signs?), algorithm (BNP before ECHO)
⢠BNP DD (What â or â )
⢠HF TTT sequencing in different scenarios , indications for iron TTT, CRT,ICD
⢠Acute heart failure work up and TTT according to hemodynamics
⢠Hyperkalemia in HF
⢠HF recovered EF management
⢠HFpEF diagnosis , role of exercise and TTT (Cutoff point ARNI EF < 57%)
⢠Heart transplantation/ LVAD indications/ contraindication and complications
⢠Temporary mechanical support choice (IABP vs ECMO)
⢠Myocarditis diagnosis (CMR imaging), management
⢠Amyloidosis types &diagnosis (GLS, CMR), management
21. Valvular guidelines
⢠Timing of surgery in asymptomatic patients (AS, MS, AR, MR, TR)
⢠Role of exercise in asymptomatic AS and MS
⢠Low-gradient AS different scenarios, role of dobutamine/Ca score and management
⢠TAVR vs. SAVR
⢠Mitral clip indications
⢠Multivalvular heart disease (Assessment of severity, limitations of different
parameters)
⢠Prosthetic valve choice, INR targets, imaging (TTE,TEE,3D)
⢠Prosthetic dysfunction , and thrombosis management
⢠Tricuspid valve intervention indications
⢠Calcific mitral stenosis assessment
⢠Rheumatic fever diagnosis , prophylaxis and management
22. Endocarditis guidelines
⢠Which patient need prophylaxis
⢠Diagnostic criteria (Imaging TTE,TEE) and empirical regimens
⢠Timing and indications of surgery
⢠Culture negative endocarditis
⢠Prognostic factors
⢠Implantable devices endocarditis
⢠Special scenarios (CVS, cerebral hge)
⢠Mimics of endocarditis ( Marantic , libman sac imaging)
23. Aorta & Peripheral guidelines
⢠Timing of intervention (TAA, AAA) in normal, bicuspid and marfan in
details ( > or ⼠is tricky )
⢠Aortic dissection diagnosis
⢠Rupture coronary sinus of Valsalva presentation
⢠Vasculitis (Takayasu)
⢠Antiplatelet in TIA, PAD
⢠Indications for carotid intervention , surgery vs. stent
24. CCS guidelines
⢠Pretest probability and risk stratification modality choice (CT, MPI,
Dobutamine echo, Invasive?)
⢠Image interpretation (Dobutamine ECHO, MPI, CMR), MPI artifacts
⢠Antianginal 1st line, 2nd line, in special scenario ( Low BP, HR, spasm,
bridge, âŚ.)
⢠Indication for angiography and revascularization (PCI vs, CABG)
⢠Lead misplacement ECG
25. ACS guidelines
⢠STEMI equivilant diagnosis (ECGs e.g. wellen , LBBB sgarbossa ,
Dewinter, LM ECG,âŚ..)
⢠Antiplatelet management in different scenario (High bleeding risk,
perioperative, duration, OAC patints)
⢠MI complications ( VSR, rupture, arrhythmia ) management
⢠Time frames for choice of TTT strategy ( PPCI vs pharmacoinvasive)
⢠MINOCA workup (CMR imaging), Mimics (e.g. Taktsubo diagnosis)
⢠SCAD imaging (Angio) and management
⢠Timing and indications of ICD
26. VT&SCD guidelines
⢠ICD indications in different scenarios
⢠Long QT diagnosis (ECG) and management
⢠Catecholenergic polymorphic VT diagnosis (ECG) and management
⢠Fascicular VT/ RVOT diagnosis (ECG) and management
⢠PVC management , indication for ablation
⢠Brugada $ diagnosis (ECG), sports?, and management
⢠ERP syndrome
⢠ARVC diagnosis (ECG and CMR), sports?, and management
⢠Sarcoidosis diagnosis (CMR, PETâ Activity) and ICD indications
⢠Causes and work up for SCD and family screening
⢠VT storm
⢠ICD appropriate vs. inappropriate shock (Atrial arrhythmia)
27. SVT & AF guidelines
⢠1st option in TTT ofâŚ.. (Read guidelines algorithms carefully)
⢠POTS diagnosis and management
⢠WPW risk stratification and management
⢠Preexcited AF diagnosis (ECG) and management
⢠Intracardiac tracing of SVT!
⢠Proper choice of rhythm control drug in different scenarios
⢠Indications for AF ablation and complications of PVI
⢠AF in HF and CRT patients
⢠Anticoagulation indications (Scores), bleeding management, antidotes
28. Pacing& syncope guidelines
⢠Heart block ECGs (Mobitz I, II, complete), indications for pacing
⢠Syncope in elderly vs. falls , 1st investigation
⢠Bi-fascicular block & syncope management
⢠Indications of pacing in reflex syncope
⢠Pacing options in heart failure with AV block
⢠MRI safety in cardiac electronic devices
⢠Pacemaker trouble shooting (ECG), complications (short, long term)
⢠Driving scenarios
29. PHTN &Pulmonary embolism guidelines
⢠Indications of lytic therapy and percutaneous intervention
⢠Choice of anticoagulation and regimens
⢠Indications of IVC filter
⢠Screening algorithm for CTEPH, risk factors
⢠PHTN types and defintions (Pre vs. post capillary ) , hemodynamic
tracing
⢠Risk stratification strata and management of PH (Drug sequencing)
30. GUCH& Pregnancy guidelines
⢠Indications of VSD, ASD, PDA closure , imaging diagnosis
⢠Indications of intervention in pulmonary stenosis
⢠TOF complications , management of pulmonary regurge (Indications)
⢠Coronary anomalies imaging (MSCT) , role of exercice stress & management
⢠Fontan and arrhythmia
⢠Eisenmenger $
⢠Anticoagulation during pregnancy
⢠Contraindication of pregnancy in cardiac patients (WHO classes), mode of delivery
⢠IE prophylaxis
⢠D.D dilated RV (TEE imaging)
⢠Management of arrhythmia (Drug safety/DC) &VHD and HTN in pregnancy
31. Perioperative guidelines
⢠Perioperative drug management (SGLT2i, ACE-I, OAC, antiplatelets,âŚ)
⢠OAC when to bridge and how
⢠NOAC management
⢠Indications for pre-op stress imaging
⢠Indications for pre-op revascularization
⢠Asymptomatic valvular heart disease management
32. Cardio-oncology guidelines
⢠Cardiotoxicity prevention, surveillance , When to hold TTT ?
⢠Long term FU plan
⢠ICI & T-CART myocarditis
⢠Arrhythmia side effects od ibrutinib (AF)
⢠5FU coronary spasm
⢠Radiotherapy
⢠Cardiac tumors
⢠Role of PET, CMR in cardiac masses
33. Dyslipidemia& DM& Prevention guidelines
⢠LDL targets in different subsets
⢠Non-statin therapy indications
⢠Statin intolerance management
⢠Statin in heart failure and hemodialysis patients
⢠Familial hypercholesterolemia diagnosis, genetic screening
⢠Lipoprotein a
⢠Risk stratification SCORE, when to calculate
⢠Role of ACE-I, aspirin , SGLT2i , Colchicine for 1ry prevention
34. Sports& HCM guidelines
⢠HCM risk assessment
⢠HCM imaging (ECHO, CMR)
⢠ICD indications
⢠Sports in HCM
⢠ECG changes in athelete, when to further investigate
⢠Exercise return post pericarditis and myocarditis in atheletes
⢠CMR LGE in athelete and management
⢠Exercise prescription in different valvular , HF, IHD scenarios
35. Pericardial & HTN guidelines
⢠Pericarditis diagnosis (CMR imaging), TTT regimens and duration
⢠Chronic, refractory pericarditis
⢠Pericardial effusion management and timing of FU
⢠Constrictive pericarditis diagnosis (CMR, hemodynamic tracing),
management
⢠Cardiac tamponade diagnosis (ECHO, hemodynamic tracing)
⢠HTN definition, stages, when to treat, combination therapy
⢠Resistant hypertension workup and management
⢠Secondary hypertension causes and workup
⢠HTN emergency workup and management
36. Final tips
⢠Try to make your own summary for important guidelines
recommendations and tips from EECC & BJCA preparatory courses
⢠Try to make MCQ key points as bullets in your notebook
⢠At least 50% of questions contains imaging (TTE,TEE,CMR,CT,PET,MPI),
or ECG which may contains a clue for MCQ, so try to focus on EECC &
BJCA imaging and ECG section